Potential Biomarkers in Metastatic Colorectal Cancer

preview_player
Показать описание
The panelists, Richard Kim, MD, and Charles S. Fuchs, MD, offer insight into the utility of PTEN mutations and other potential targets as biomarkers for metastatic colorectal cancer.
Рекомендации по теме